Humana Inc. ($HUM) Stock Forecast: Up 5.1% Today

What is Humana Inc.?

Humana Inc. ($HUM) is a leading healthcare company in the United States, offering a range of insurance products and health services to its customers. The company focuses on providing innovative solutions to improve the well-being of its members.

Why is Humana Inc. going up?

HUM stock is up 5.1% on Dec 11, 2025 17:51

• The bullish movement in Humana Inc. ($HUM) stock today can be attributed to the increased holdings by institutional investors like State Street Corp and California Public Employees Retirement System, indicating confidence in the company's growth prospects and financial performance.
• The announcement of Humana Healthy Horizons in Oklahoma funding six nonprofits with $295,500 showcases the company's commitment to addressing critical health-related social needs, which may have positively influenced investor sentiment.
• Analysts maintaining a "Hold" rating on Humana with a consensus target price of $296.84 suggests a stable outlook for the stock, supported by the company's strategic initiatives and dividend payouts.
• Overall, the positive market movement of Humana Inc. ($HUM) today reflects investor optimism fueled by institutional investments, community impact initiatives, and steady growth projections in the healthcare sector.

HUM Price Chart

HUM Technical Analysis

HUM News

Humana Inc. $HUM Shares Bought by State Street Corp

State Street Corp increased its holdings in Humana Inc. by 1.1% in the second quarter, now owning 4.47% of the company's stock worth $1.32 billion. Several other institutional investors also adjusted their stakes in Humana, with a significant boost from Bank of Nova Scotia. Analyst ratings for Humana are varied, with a consensus "Hold" rating and an average price target of $296.84, while the company recently announced a quarterly dividend of $0.885 per share.

https://www.marketbeat.com/instant-alerts/filing-humana-inc-hum-shares-bought-by-state-street-corp-2025-12-11/

Nutex Health’s Micro-Hospitals Deliver Outsized Returns And Growth

Nutex Health, a company operating physician-led micro-hospitals, has shown significant growth and outsized returns, with shares soaring 439.5% over the past year. Its success is attributed to its unique model, strong arbitration wins (over 85% of IDR claims), and rapid expansion. Despite trading at a steep discount, the company faces risks related to reimbursement uncertainty, regulatory compliance, and market volatility.

https://finimize.com/content/nutx-asset-snapshot

CVS Health Targets Steady Gains With A Revamped Game Plan

CVS Health has announced a new strategic plan aiming for steady, mid-teens earnings growth through 2028, driven by artificial intelligence and business streamlining. The company is focusing on higher-margin segments like Health Benefits and leveraging AI in its Health Services arm, which is gaining market confidence due to its stability in the turbulent healthcare sector. This strategy aligns with a broader industry trend of technology-driven growth, emphasizing data-driven approaches to improve patient experiences and control costs.

https://finimize.com/content/cvs-health-targets-steady-gains-with-a-revamped-game-plan

Humana Healthy Horizons in Oklahoma (NYSE: HUM) funds six nonprofits with $295,500

Humana Healthy Horizons in Oklahoma has awarded $295,500 in Community Impact Awards to six non-profit organizations. These funds will be used to address critical health-related social needs across Oklahoma, such as "Food as Medicine" programs, stable housing access, and employment opportunities. The initiative aligns with Oklahoma's health priorities and aims to support Humana's Medicaid population in the state, particularly addressing financial strain and food insecurity among members.

https://www.stocktitan.net/news/HUM/humana-healthy-horizons-in-oklahoma-selects-six-nonprofits-to-4y8quzzne2e5.html

California Public Employees Retirement System Has $53.27 Million Stock Holdings in Humana Inc. $HUM

The California Public Employees Retirement System increased its stake in Humana Inc. (NYSE:HUM) by 11.9% to 217,875 shares, valued at approximately $53.27 million. Other institutional investors also made significant moves, contributing to 92.38% institutional ownership. Analysts currently have a "Hold" rating on Humana with a consensus target price of $296.84.

https://www.marketbeat.com/instant-alerts/filing-california-public-employees-retirement-system-has-5327-million-stock-holdings-in-humana-inc-hum-2025-12-10/

Trending Today

Helmerich & Payne Inc. ($HP) Stock Forecast: Down 5.1% Today

Ambarella Inc. ($AMBA) Stock Forecast: Down 5.0% Today

Credo Technology Group ($CRDO) Stock Forecast: Down 5.2% Today

Penn National Gaming Inc. ($PENN) Stock Forecast: Up 6.0% Today

Astera Labs Inc ($ALAB) Stock Forecast: Down 5.0% Today

Cencora Inc. ($COR) Stock Forecast: Down 2.4% Today

Pfizer Inc. ($PFE) Stock Forecast: Down 4.4% Today

Xerox Corporation ($XRX) Stock Forecast: Up 5.3% Today

Cognex Corporation ($CGNX) Stock Forecast: Up 5.0% Today

Micron Technology Inc. ($MU) Stock Forecast: Down 5.4% Today

Humana Inc. Price History

02.09.2025 - HUM Stock was down 0.2%

• Humana's stock experienced a bearish movement today, possibly due to:
• Pressure from high benefit ratios and costs impacting the company's profitability.
• Investor concerns raised by an investigation initiated by Bragar Eagel & Squire, P.C., leading to a loss in investor confidence.
• Despite benefiting from rising premiums and Medicare growth, these positive factors might have been overshadowed by the negative aspects, contributing to the bearish trend.
• The comparison with Akero Therapeutics, Inc. might have also influenced investor sentiment, especially if Akero Therapeutics has been outperforming Humana in the sector, leading to a shift in investment focus away from Humana.

03.11.2025 - HUM Stock was up 5.7%

• The collaboration between Humana and Epic to automate insurance verification processes has likely boosted investor confidence in the company's operational efficiency and potential cost savings, contributing to the bullish movement.
• Panagora Asset Management Inc.'s significant increase in stake in Humana indicates growing investor interest and confidence in the company's future performance, especially after beating Q3 earnings estimates.
• Despite the positive momentum, the investigation into potential stockholder claims and allegations of illegal kickbacks may have initially caused some uncertainty and a slight decline in the stock price, but the overall market sentiment remains positive given the company's strong financial performance and strategic initiatives.

03.11.2025 - HUM Stock was up 6.4%

• Recent positive investor sentiment and increased stake by Panagora Asset Management Inc. have contributed to Humana's bullish movement, following a strong Q3 earnings performance.
• The collaboration to automate insurance verification processes with Epic has improved operational efficiency and demonstrated a commitment to enhancing patient outcomes through technology.
• Speculation surrounding CVS Health's forthcoming investor day and a positive industry outlook have also likely influenced the uptrend in Humana's stock.
• Overall, strategic initiatives, robust financial performance, and partnerships within the industry are driving investor confidence and boosting the stock's momentum.

26.10.2025 - HUM Stock was up 5.2%

• Humana's bullish movement today could be attributed to the national coverage agreement signed with Plus Therapeutics for CNSide® Cerebrospinal Fluid Assay for Metastatic CNS Cancer. This partnership and expansion of services could have positively impacted investor sentiment towards Humana's growth prospects in the healthcare sector.
• UnitedHealth's push towards a hybrid care model, combining digital tools with in-person care, may have also influenced the bullish trend in the healthcare industry, including companies like Humana. This strategic approach to healthcare delivery could signal potential industry-wide shifts and opportunities for growth.
• The market's positive reaction to Humana's strategic partnerships and focus on innovative healthcare solutions indicates investor confidence in the company's ability to adapt to evolving market trends and drive value for its stakeholders.

10.09.2025 - HUM Stock was down 6.7%

• The bearish movement in Humana's stock today could be attributed to an ongoing investigation, causing uncertainty among investors.
• The news of a competitor expanding its initiative to reduce hospital readmissions may have negatively impacted Humana's stock, signaling increased competition in the healthcare sector.
• Despite a recent jump in Humana's share price, the lack of promising trends in earnings estimate revisions may have contributed to today's bearish movement.
• Investors might be reacting to the overall sentiment in the healthcare industry, leading to a sell-off in Humana's stock amidst uncertainties about the company's future prospects.

11.11.2025 - HUM Stock was up 5.4%

• Institutional investors, including State Street Corp, are increasing their holdings in Humana, indicating growing confidence in the company's future prospects, which is contributing to the bullish movement in the stock.
• CVS Health recently announced a strategic plan that emphasizes technology-driven growth and higher-margin segments, positively impacting the healthcare sector and potentially boosting investor sentiment towards companies like Humana.
• Humana's dedication to community impact through funding non-profit organizations in Oklahoma is in alignment with its values and enhances its reputation, attracting socially responsible investors.
• California Public Employees Retirement System and Federated Hermes Inc. have increased their stake in Humana, reinforcing the positive outlook on the company. Analysts maintain a "Hold" rating but with a target price indicating potential growth ahead.

19.08.2025 - HUM Stock was down 5.3%

• The bearish movement in Humana's stock today could be attributed to an investigation initiated by the former Attorney General of Louisiana, Charles C. Foti, Jr., Esq., into the officers and directors of the company. This news might have raised concerns among investors about potential legal issues or regulatory challenges that could impact Humana's operations and financial performance.
• The uncertainty surrounding the investigation could have led to a lack of confidence in the company's leadership and governance practices, prompting investors to sell off their positions in Humana's stock.
• As investors typically react negatively to legal investigations and regulatory scrutiny, the bearish trend in Humana's stock today reflects the market's cautious sentiment towards the company's current situation and the potential implications of the ongoing probe.

01.09.2025 - HUM Stock was down 4.6%

• The bearish movement in Humana's stock today could be attributed to the unusual options activity indicating that high-rolling investors have taken a bearish stance on the company.
• The investigation by Bragar Eagel & Squire, P.C. on behalf of long-term stockholders might have raised concerns among investors, leading to a sell-off in the stock.
• The comparison with Akero Therapeutics and other medical peers in the sector may have highlighted relative underperformance, further dampening investor sentiment towards Humana.
• Overall, the combination of negative news flow and bearish market sentiment from high-profile investors likely contributed to the significant downward movement in Humana's stock price today.

11.11.2025 - HUM Stock was up 5.1%

• The bullish movement in Humana Inc. ($HUM) stock today can be attributed to the increased holdings by institutional investors like State Street Corp and California Public Employees Retirement System, indicating confidence in the company's growth prospects and financial performance.
• The announcement of Humana Healthy Horizons in Oklahoma funding six nonprofits with $295,500 showcases the company's commitment to addressing critical health-related social needs, which may have positively influenced investor sentiment.
• Analysts maintaining a "Hold" rating on Humana with a consensus target price of $296.84 suggests a stable outlook for the stock, supported by the company's strategic initiatives and dividend payouts.
• Overall, the positive market movement of Humana Inc. ($HUM) today reflects investor optimism fueled by institutional investments, community impact initiatives, and steady growth projections in the healthcare sector.

05.10.2025 - HUM Stock was down 7.3%

• Despite surpassing earnings and revenue expectations in the third quarter, Humana's stock faced significant downward pressure.
• Concerns regarding future growth potential may have influenced the market's negative response, despite the company outperforming financially.
• Investors could be considering factors beyond quarterly results, such as future guidance and industry trends, contributing to the stock's bearish performance.
• The presence of a hammer chart pattern and positive trend in earnings estimates, as highlighted elsewhere, might not have been adequate to counter the overall market sentiment impacting Humana's stock.

05.10.2025 - HUM Stock was down 7.3%

• Despite surpassing Q3 earnings expectations and showing robust premium growth, Humana stock underwent a bearish trend.
• The negative market response may be attributed to increased expenses and declining memberships affecting the company’s performance, notwithstanding the positive earnings and revenue outcomes.
• Shareholders may have expressed dissatisfaction with the lower quarterly earnings per share in comparison to the previous year, falling short of analysts' projections.
• The fluctuating U.S. stock futures market and attention directed towards other companies such as McDonald's might have also influenced the downward movement in Humana stock today.

05.10.2025 - HUM Stock was down 8.7%

• Despite beating Q3 earnings and revenue estimates, Humana's stock experienced a bearish movement, possibly due to analysts revising expectations downwards for the quarter.
• The hammer chart pattern indicating potential support for the stock might not have been enough to offset concerns about the decrease in earnings per share compared to the previous year.
• The focus on rising premiums and service revenues to boost Q3 earnings may not have fully convinced investors, leading to a sell-off in the stock.
• Overall, the mixed market sentiment and cautious outlook from analysts could have contributed to the bearish movement in Humana's stock today.